-
Jan 8, 2025 | 
nmanet.org | Jennifer Young
The National Medical Association (NMA) invites you to submit abstracts for presentation at the 2025 NMA Annual Convention and Scientific Assembly to be held July 19-23, 2025, in Chicago, IL.
-
Oct 11, 2024 | 
newsexaminer.com | Jennifer Young
As fall rolls in and the weather cools down, we’re excited to announce that we’ve met our fundraising goal for Windows of Hope! Thanks to our community support, our new windows are scheduled for installation the week of October 21. Please note, the Hope Center will be closed from Thursday, October 17-Friday, November 1st. This will allow time for the installation of windows and clean up.
-
Sep 21, 2024 | 
newsexaminer.com | Jennifer Young
Our largest fundraiser of the year was Thursday, September 12, at the John Miller Center in Roberts Park. This is always an encouraging, well attended event of over 200 like-minded individuals in our community. Thank you to our caterers, C & T Catering, Ole Rooste, and Your Way Catering, for providing the delicious food!Our theme this year was “Hope in the Night“. We chose this theme because there have been several opportunities for night faith this year. We all prefer full sun faith.
-
Sep 13, 2024 | 
cfp.ca | Emélie Braschi |Jennifer Young |G. Michael Allan
Clinical questionWhat are the risks and benefits of using topical corticosteroids for atopic dermatitis in children and adults? Bottom lineWhile evidence is limited, topical steroids are effective against atopic dermatitis and efficacy likely increases with potency. Use once daily seems as effective as twice daily. Treatment 2 days per week of areas with frequent recurrent flares will help about 60% avoid a flare versus about 30% using a placebo over 16 weeks.
-
Sep 13, 2024 | 
cfp.ca | Emélie Braschi |Jennifer Young |G. Michael Allan
Question cliniqueQuels sont les risques et les bienfaits d’utiliser des corticostéroïdes topiques pour la dermatite atopique chez les enfants et les adultes? RésultatsBien que les données probantes soient limitées, les corticostéroïdes topiques sont efficaces contre la dermatite atopique, et leur efficacité augmente probablement en fonction de leur puissance. L’application 1 fois par jour semble aussi efficace que l’application 2 fois par jour.
-
Aug 1, 2024 | 
brainandlife.org | Jennifer Young
First of all, you are not alone. Patients miss doses for a variety of reasons—everything from a change in routine, such as travel or an unscheduled appointment or event, to a lapse in memory. But skipping a dose can render medication less effective or cause symptoms to reappear. For example, missing a dose of blood pressure medication may require additional blood pressure monitoring throughout the day. And forgetting to take blood thinners may raise the risk of having a blood clot or stroke.
-
Jul 30, 2024 | 
pericles.pericles-prod.literatumonline.com | Qiang Zhu |Xu Gao |Jennifer Young |Jing Wen Koo
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description admt202302230-sup-0001-SuppMat.docx1.8 MB Supporting Information References 1a) , , , , Gels 2023, 9, 260; b) , , , , , Frontiers in Materials 2020, 7, 76; c) , , Adv. Funct. Mater. 2022, 32, 2205345; d) , , , , , , , , , , Sci. Adv. 2021, 7, eaba4261. 2a) , , , , , , , , Communications Materials 2023, 4, 75; b) , , , , , ACS Appl. Mater.
-
May 14, 2024 | 
cfp.ca | Jennifer Young |G. Michael Allan |Betsy Thomas
Clinical questionDo cranberry products prevent recurrent urinary tract infections (UTIs)? Bottom lineEvidence is of low quality because of potential publication bias, small studies, and unblinding. If biases are disregarded, cranberry products might reduce the proportion of women with recurrent UTIs to 18% vs 24% with placebo over 1 year or less. Results are inconsistent between populations (eg, children with recurrent UTIs may benefit but not institutionalized elderly patients or pregnant women).
-
Mar 18, 2024 | 
cfp.ca | Jennifer Young |Erin Lee |Adrienne Lindblad |Jamie Falk
Clinical questionAre orexin antagonists safe and effective for treatment of primary insomnia? Bottom lineOrexin antagonists help people fall asleep about 9 minutes faster and increase total sleep time by about 19 minutes versus placebo over the course of 1 to 3 months. About 8% of those taking orexin antagonists will experience next-day somnolence compared with 2% taking placebo. EvidenceSeven systematic reviews of RCTs were found1-7; we report mainly on the most recent and comprehensive review.
-
Feb 21, 2024 | 
cfp.ca | Jennifer Young |G. Michael Allan |Betsy Thomas |Darren Pasay
One of the most common presentations in primary care is the uncomplicated urinary tract infection (UTI), characterized by patient reports of increased frequency, dysuria, urgency, incomplete emptying, or hematuria. It is traditionally ascribed to bacterial overgrowth restricted to the bladder. Another common situation is that of abnormal urinalysis or culture findings from someone (usually 60 or older) who has nonspecific symptoms but no clear urinary symptoms.
